JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28 | +86.7% | 15,195 | +11.4% | 0.00% | – |
| Q4 2022 | $15 | -100.0% | 13,635 | +1.0% | 0.00% | – |
| Q3 2022 | $32,000 | -33.3% | 13,495 | -14.4% | 0.00% | -100.0% |
| Q2 2022 | $48,000 | -72.4% | 15,768 | -32.6% | 0.00% | 0.0% |
| Q3 2021 | $174,000 | +216.4% | 23,393 | +44.3% | 0.00% | – |
| Q4 2018 | $55,000 | -81.3% | 16,213 | -29.7% | 0.00% | -100.0% |
| Q4 2017 | $294,000 | – | 23,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |